Share

February 2013; 3 (1) Clinical and Ethical Challenges

Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions

Megan Hyland, Robert A. Bermel, Jeffrey A. Cohen
First published February 18, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e318283ff8e
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1213

Share

Article Information

vol. 3 no. 1 15-21
DOI: 
https://doi.org/10.1212/CPJ.0b013e318283ff8e
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published February 18, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Megan Hyland, MD,
    2. Robert A. Bermel, MD and
    3. Jeffrey A. Cohen, MD
  1. Megan Hyland, MD,
    2. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Robert A. Bermel, MD and
    3. Scientific Advisory Boards:

    1. Novartis, Questcor

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Biogen Idec, Teva Neuroscience, Novartis

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Biogen Idec, Teva Neuroscience, Astellas

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Multiple Sclerosis Society Research Grant RG4449A1/T

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jeffrey A. Cohen, MD
    4. Scientific Advisory Boards:

    1. Biogen Idec3/11/2011, Consulting meeting, $9100Elan12/10/2010, Consulting meeting, $2250Novartis11/19/2010, Consulting meeting, $6600Teva4/22/2011, Consulting meeting, $36001/23/2012, Consulting meeting, $2500Vaccinex5/15/2011, Consulting meeting, $4000

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Novartis4/12/2011, Speaker, $2500

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Cambridge University Press, JA Cohen and RA Rudick, eds, Multiple Sclerosis Therapeutics, 4th edition, 2011

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support paid to my institution from: Biogen Idec, Genzyme, Novartis, Receptos, Synthon, Teva

    Research Support, Government Entities:

    1. Department of Defense, PR093324, PI, 2010-14NIH, 1 RO1 NS074787, 2011-4

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Nancy Davis Center Without Walls, 2007, $25,000Nancy Davis Center Without Walls, 2008, $25,000

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (MH), University of Rochester Medical Center, Rochester, NY; and Mellen Center for MS Treatment and Research (RAB, JAC), Neurological Institute, Cleveland Clinic, Cleveland, OH.
  1. Correspondence to:
    megan_hyland{at}urmc.rochester.edu
View Full Text

Article usage

Article usage: February 2013 to April 2023

AbstractFullPdfSource
Feb 20133162936Highwire
Mar 20133181517Highwire
Apr 20131861111Highwire
May 201313218Highwire
Jun 20138103Highwire
Jul 20135403Highwire
Aug 20136721Highwire
Sep 20135203Highwire
Oct 20134301Highwire
Nov 20136200Highwire
Dec 20136700Highwire
Jan 20144902Highwire
Feb 20141101Highwire
Mar 20143303Highwire
Apr 20145502Highwire
May 20142000Highwire
Jun 20142900Highwire
Jul 20143000Highwire
Aug 20142001Highwire
Sep 20143402Highwire
Oct 20142000Highwire
Nov 20142302Highwire
Dec 20141800Highwire
Jan 20151900Highwire
Jan 201505713pmc
Feb 20151601Highwire
Feb 20150657pmc
Mar 20153921Highwire
Mar 201506513pmc
Apr 20152701Highwire
Apr 20150514pmc
May 20152002Highwire
May 20150555pmc
Jun 20151100Highwire
Jun 20150416pmc
Jul 2015900Highwire
Jul 20150574pmc
Aug 20151611Highwire
Aug 20150517pmc
Sep 20152301Highwire
Sep 20150587pmc
Oct 20152423Highwire
Oct 201506310pmc
Nov 20151500Highwire
Nov 20150567pmc
Dec 20152200Highwire
Dec 20150595pmc
Jan 20162600Highwire
Jan 20160474pmc
Feb 20162000Highwire
Feb 201604810pmc
Mar 20161810Highwire
Mar 201605512pmc
Apr 2016700Highwire
Apr 20160505pmc
May 20162200Highwire
May 201606311pmc
Jun 20163001Highwire
Jun 20160467pmc
Jul 20162300Highwire
Jul 201603912pmc
Aug 20161300Highwire
Aug 201607410pmc
Sep 20161800Highwire
Sep 20160527pmc
Oct 20162000Highwire
Oct 20160746pmc
Nov 20162500Highwire
Nov 20160495pmc
Dec 20162600Highwire
Dec 20160643pmc
Jan 20173500Highwire
Jan 20170613pmc
Feb 20171500Highwire
Feb 201708611pmc
Mar 20172900Highwire
Mar 20170767pmc
Apr 20172400Highwire
Apr 201749292pmc
May 20172800Highwire
May 201755055pmc
Jun 20171100Highwire
Jun 201755254pmc
Jul 2017400Highwire
Jul 201729192pmc
Aug 20171200Highwire
Aug 20175132139pmc
Sep 20171000Highwire
Sep 201728289pmc
Oct 20171600Highwire
Oct 201788995pmc
Nov 20171710Highwire
Nov 201737980pmc
Dec 20171300Highwire
Jan 20181411Highwire
Feb 20181600Highwire
Mar 20183300Highwire
Apr 20182500Highwire
Apr 201816569pmc
May 20185641Highwire
Jun 20182300Highwire
Jun 201864144pmc
Jul 20183310Highwire
Aug 20183700Highwire
Aug 201845661pmc
Sep 20183401Highwire
Oct 20182800Highwire
Nov 20182350Highwire
Dec 20182900Highwire
Jan 20194900Highwire
Feb 20192800Highwire
Mar 20192330Highwire
Apr 20191001Highwire
May 20191700Highwire
Jun 20191110Highwire
Jul 20191300Highwire
Aug 201911140Highwire
Sep 20191410Highwire
Oct 20191602Highwire
Nov 20192923Highwire
Dec 20191700Highwire
Jan 20201821Highwire
Feb 20202204Highwire
Mar 2020910Highwire
Apr 20202010Highwire
May 20201400Highwire
Jun 2020110Highwire
Jul 2020410Highwire
Aug 202010802Highwire
Sep 20201731Highwire
Oct 20201900Highwire
Nov 20201411Highwire
Dec 20201000Highwire
Jan 2021820Highwire
Feb 20211311Highwire
Mar 20211911Highwire
Apr 20211410Highwire
May 20211130Highwire
Jun 2021501Highwire
Jul 20212810Highwire
Aug 20212410Highwire
Sep 20211220Highwire
Oct 20211900Highwire
Nov 20211700Highwire
Dec 20211200Highwire
Jan 20221810Highwire
Feb 20222222Highwire
Mar 20223501Highwire
Apr 20223310Highwire
May 20221710Highwire
Jun 20222400Highwire
Jul 20222301Highwire
Aug 20221400Highwire
Sep 20221610Highwire
Oct 20222923Highwire
Nov 20224406Highwire
Dec 20221611Highwire
Jan 20232500Highwire
Feb 20232200Highwire
Mar 2023600Highwire
Apr 2023500Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles